Drug Safety Legislation Unlikely, BIO CEO Greenwood Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Trade association's new chief sees no "great case for, or inclination on the part of the Senate leadership...to legislate on this topic." Upcoming Health Committee hearings may persuade senators to withdraw proposed legislation on drug safety issues, Greenwood says.